业务
货币单位:人民币
2023/FY
名称营收比例
Chemical business (WuXi Chemistry)291.71亿72.31%
Testing Business (WuXi Testing)65.4亿16.21%
Biology business (WuXi Biology)25.53亿6.33%
Advanced Therapy CTDMO Business (WuXi ATU)13.1亿3.25%
Domestic New Drug Research and Development Service Unit (WuXi DDSU)7.26亿1.80%
其他业务4,104.87万0.10%
查看全部
地区
货币单位:人民币
2023/FY
名称营收比例
海外329.69亿81.73%
国内73.3亿18.17%
其他业务4,104.87万0.10%
特别调整总额10--
